Retracting the Esophagus During AF Ablation

Status unconfirmed · Not applicable

Conditions studied: Atrial Fibrillation, Esophageal Fistula, Cardiac Arrhythmia

In brief

This Study is designed to determine the outcome and effect of implementation of Esophageal Stylet as a strategy to minimize the risk of esophageal injury during the atrial fibrillation catheter ablation procedure.

Key facts

Study ID

NCT02665442

Run by

Northeast Scientific, Inc.

People needed

40

Starts

2016-01-01

Expected to finish

2018-01-01

Last updated by the study team

2016-01-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or above for the Patient or legal representative to provide informed consent.
• Documented paroxysmal or persistent Atrial Fibrillation by a Cardiologist and EKG finding.
• The patient will undergo Atrial Fibrillation catheter ablation as a treatment plan.

You may not qualify if…

• Bleeding disorder.
• Dysphagia to solid and liquid or any documented esophageal masses or cancer.
• Esophageal varices, diverticulum, esophageal web, upper GI bleeding, or hiatal hernia.

Where it is running

• Yale New Haven Hospital — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.